Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEBE III erythropoietin trial in first acute myocardial infarction
NL-OMON26840Not yet recruiting
- Sponsor
- Netherlands Heart Institute
- Start
- Sep 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in myocardial infarction (MI) comparing Eprex with Placebo (2 arms). Primary endpoint: Left ventricular ejection fraction. Planned start Sep 2006; status: not yet recruiting.
02
Drugs
epoetin alfa
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON26840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26840.